Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINC-II for HIV-infected PWID
NCT03290391Phase 4Completed
- Sponsor
- Boston Medical Center
- Start
- Sep 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in opioid use disorder (OUD), sponsored by Boston Medical Center. Started Sep 2018; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03290391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03290391.